Yes, not a good sign on the face of it, especially since we're waiting to hear if the FDA will give the OK for the ADHD trial. I don't like the looks of it, but there are numerous other explanations for Tran's departure that wouldn't involve some dire developments with ADHD or SA. But I'll feel a lot better when we hear that ADHD is definitely going to happen. Maybe Tran just got a better job offer or something.
News 
Market Data 
Discover 
AI
